MetaCap

Savara Inc. Company Profile

NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.92+0.09 (+1.86%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Savara at a glance

Savara Inc. (NASDAQ: SVRA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Yardley, PA. Savara is led by Mr. Matthew Pauls J.D., M.B.A. and employs about 70 people. At a market capitalization of $992.4 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001160308, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Savara do?

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.

Business description based on the company's public filings.

Company information

Legal name
Savara Inc.
Ticker
NASDAQ: SVRA
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Matthew Pauls J.D., M.B.A.
Employees
70
Headquarters
The Tannery Building, Yardley, PA, United States
Phone
(512) 614-1848
Website
savarapharma.com
Market cap
$992.37M
SEC CIK
0001160308
Latest annual report
10-K · Mar 13, 2026

Companies similar to Savara

SVRA peer companies
CompanyPrice% ChgMarket capCompare
ANLAdlai Nortye Group Ltd. ADR15.62+0.71%$1.01Bvs SVRA
AKTSAktis Oncology Inc.18.15+2.31%$1.01Bvs SVRA
SPTXSeaport Therapeutics Inc.18.15+1.34%$971.58Mvs SVRA
ANROAlto Neuroscience Inc.24.37+1.41%$956.33Mvs SVRA
OPKOPKO Health Inc.1.38+0.73%$1.03Bvs SVRA
KURAKura Oncology Inc.10.60+0.76%$942.98Mvs SVRA
MNKDMannKind Corporation3.29-3.80%$1.06Bvs SVRA
ALMSAlumis Inc.7.16+2.73%$926.76Mvs SVRA

Related